Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

April 28, 2009

Aquamid a Safe and Effective Treatment for Facial Wasting

Aquamid (polyacrylamide hydrogel) injections are a safe and long-lasting treatment for facial wasting, according to a study published in the April issue of AIDS Research and Human Retroviruses and reported by aidsmap.

Though the percentage of people who develop facial wasting, or lipoatrophy, has diminished since health care providers moved away from prescribing the antiretrovirals Zerit (stavudine) and Retrovir (zidovudine), a significant number of people still have untreated lipoatrophy. Moreover, the two fillers approved in the United States to treat the condition are temporary treatments and must usually be reapplied to maintain facial fullness.

To determine the long-term effectiveness and safety of a new, permanent filler called Aquamid, Eugenia Negredo, MD, from the Universitat Autònoma de Barcelona, and her colleagues treated 145 people with HIV and varying degrees of facial wasting. Most of the patients were male and had been infected with HIV for about 16 years. The average age was 47, and nearly two thirds had severe facial lipoatrophy. The patients received injections of Aquamid every three weeks until a desired fullness in the face was achieved. The authors did not state the average number of treatments that were given, but the average total volume of Aquamid used was 5.5 milliliters.

Negredo’s team found that Aquamid implants were relatively safe. Only one patient had a serious infection, which was treatable with oral antibiotics. Nineteen percent had small nodules that were not readily visible, and 6 percent had hardening of the facial skin. Just 9 percent of the patients required follow-up injections after reaching a desired facial fullness during the follow-up period averaging four years.

While the authors conclude that their study demonstrates the relative efficacy and safety of Aquamid, they also caution that “continued and prolonged follow-up of these patients is recommended to treat complications and detect unexpected long-term adverse reactions.”

Search: Aquamid, polyacrylamide hydrogel, facial wasting, facial filler, lipoatrophy, Eugenia Negredo


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 4 (of 4 total)    

pozoid, Waterkant, Germany, 2009-05-09 14:11:34
Dr Delpino in Madrid has been doing this treatment for some years. Here is a video on his site of the treatment being done - www.drdelpino.com/frontend/drdelpino/Videos-De-Demostracion-vn2695-vst235 I intend to have the treatment.

don, memphis, 2009-04-30 21:46:50
hi, hope this gets cleared for USA use. I just spent over 2000.00 i did not really have, but i was really down about the facial wasting. i have been + for over 16 yrs, 47 yo this year, on trizivir x 6 yrs, worked great, but in the last 1.5 yrs it has just dropped weight off my face. i am an RN and around many people all day, i was really embarrassed. i had two different fillers put in, suppose to last about 9 mths, but it has not even lasted a mth, though better, i cant afford anymore

pablo, , 2009-04-30 16:21:12
P L E A S E give us the whole enchilada on this article... who, where, how much, how long, do I need RX? what are side effects? can my ID doctor refer me to get threatment? Whats the minimum CD4 count needed to participate??? your minuscule articles seem like an empty Icon on my desktop.. like a boat loaded with straw in the middle of the opcean and going no where very, very s l o w ...

Allan, Chico, 2009-04-30 12:07:49
This article was very interesting & sounds like a promising treatment, however it didn't give enough information. Only aroused curiosity. Is this Product available & approved for use in the USA? What are the costs involved for treatment? Where & who provides access to the procedures.

comments 1 - 4 (of 4 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy